This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rossi, A. Articles by Seward, J. B. Search for Related Content PubMed PubMed Citation Articles by Rossi, A. Articles by Seward, J. B.

Natriuretic peptide levels in atrial fibrillation

A prospective hormonal and Doppler-echocardiographic study

Andrea Rossi, MD^*, Maurice Enriquez-Sarano, MD, FACC^*, John C. Burnett, Jr., MD^*, Amir Lerman, MD^*, Martin D. Abel, MD and James B. Seward, MD, FACC^*

^* Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
Division of Cardiovascular/Thoracic Anesthesia, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA

View larger version (38K): [in a new window]   Figure 1 N-ANP levels in patients stratified by heart failure functional class according to NYHA class I, II, and III or IV. In each class, the left bar represents patients with sinus rhythm (SR) and the right bar, patients with A-Fib. Bar height represents the mean value; the mean ± SD is indicated in each bar. The p values are those noted in the two-way ANOVA.

View larger version (33K): [in a new window]   Figure 2 BNP levels in patients stratified by heart failure functional class according to NYHA class I, II, and III or IV. In each class, the left bar represents patients in sinus rhythm (SR) and the right bar, patients in A-Fib. Bar height represents the mean value; the mean ± SD is indicated in each bar. The p values are those noted in the two-way ANOVA.